Bromodomain-containing protein 3D structures: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 34: | Line 34: | ||
**[[6u61]], [[6u8h]], [[6ulq]] – hBRD2 bromodomain 1 + peptide <br /> | **[[6u61]], [[6u8h]], [[6ulq]] – hBRD2 bromodomain 1 + peptide <br /> | ||
**[[3oni]] – hBRD2 residues 224-335 + inhibitor<br /> | **[[3oni]] – hBRD2 residues 224-335 + inhibitor<br /> | ||
**[[3aqa]], [[2ydw]], [[2yek]], [[4a9e]], [[4a9f]], [[4a9h]], [[4a9i]], [[4a9j]], [[4a9m]], [[4a9n]], [[4a9o]], [[4alh]], [[4akn]], [[4alg]], [[4uyf]], [[4uyg]], [[4uyh]], [[6db0]], [[6ddi]], [[6jke]], [[6k05]], [[6ony]], [[6tq2]], [[7dpn]], [[7dpo]], [[7env]], [[7lah]], [[7lai]], [[7laj]], [[7lau]], [[7lay]], [[7npy]], [[7mpz]], [[7nq0]], [[7nq1]], [[7nq2]],[[7nq3]], [[7nq5]], [7nq7]], [[7nq8]], [[7nq9]], [7nqi]], [[7nqj]], [[7oe4]], [[7oe5]], [[7oe6]], [[7oe8]], [[7oe9]], [[7oep]], [[7oer]], [[7oes]], [[7oet]], [[7ogy]], [[7usi]] – hBRD2 | **[[3aqa]], [[2ydw]], [[2yek]], [[4a9e]], [[4a9f]], [[4a9h]], [[4a9i]], [[4a9j]], [[4a9m]], [[4a9n]], [[4a9o]], [[4alh]], [[4akn]], [[4alg]], [[4uyf]], [[4uyg]], [[4uyh]], [[6db0]], [[6ddi]], [[6jke]], [[6k05]], [[6ony]], [[6tq2]], [[7dpn]], [[7dpo]], [[7env]], [[7lah]], [[7lai]], [[7laj]], [[7lau]], [[7lay]], [[7npy]], [[7mpz]], [[7nq0]], [[7nq1]], [[7nq2]],[[7nq3]], [[7nq5]], [[7nq7]], [[7nq8]], [[7nq9]], [[7nqi]], [[7nqj]], [[7oe4]], [[7oe5]], [[7oe6]], [[7oe8]], [[7oe9]], [[7oep]], [[7oer]], [[7oes]], [[7oet]], [[7ogy]], [[7usi]] – hBRD2 bromodomain 1 + inhibitor<br /> | ||
**[[7lak]] – hBRD2 bromodomain 1 + drug<br /> | **[[7lak]] – hBRD2 bromodomain 1 + drug<br /> | ||
**[[7vrh]], [[7vrk]], [[7vro]], [[7vrz]], [[7vsf]] – hBRD2 bromodomain 1 + purine derivative<br /> | **[[7vrh]], [[7vrk]], [[7vro]], [[7vrz]], [[7vsf]] – hBRD2 bromodomain 1 + purine derivative<br /> | ||